EASL Education
@EASLedu
@EASLedu brings you the latest on #liver research & education. Visit #EASLCampus ----------------- EASL does not express any political opinion. RT ≠ endorsement
#LiverX, don't miss your chance to apply for the @EASLnews - @AASLDtweets Masterclass 2025 for a unique opportunity to grow as a future leader in academic hepatology.🤩 🗓️ Deadline: 13 July 2025 📍 Éincourt-Sainte-Marguerite, France 🔗 More info below 👇 @Yujun__Wong…
Last chance to apply for the EASL-@AASLDtweets Masterclass! This is a key opportunity to sharpen your leadership, communication & career skills! From mentorship to publishing, negotiation to networking — prepare to thrive in academic & clinical life. ❗Application deadline: this…
As we bid farewell to Jaume Bosch, we also witness the continuity of his legacy. Laia’s excellent PhD defense in liver vascular pathobiology reflects the lasting influence of his scientific and inspiring work. 👏🏼 Congrats Dr Abad-Jordà! Proud of you! Co-directed w @anitabites
EASL joins the global hepatology community in mourning the passing of Prof. Jaime Bosch, a visionary clinician-scientist, educator, and leader whose legacy has shaped our field over the past five decades. From pioneering research in portal hypertension to mentoring generations…
👇👇👇👇👇👇👇👇 The @EASLedu Fellowships are back! We look forward to hearing from you 👂Please do apply.
🆕We are excited to announce the launch of the new Fellowship Programme! Are you looking to grow your skills and connect with peers across Europe? Do you want to advance your research in liver disease? Discover our two fellowship types and apply by 1 September 2025! 🔗…
🧒➡️🧑 From paediatric to adult care—are we ready? What every adult hepatologist needs to know about transition clinics 📖 doi.org/10.1136/flgast… 📌 Learn how to: ✅ Build effective transition pathways ✅ Support adherence in rare liver disease ✅ Avoid drop-out & late…
Two key points that we need to remember about the new SLD (Steatotic Liver Disease) nomenclature: 1️⃣ SLD ≠ MASLD — it also includes Alcohol-Related Liver Disease (ALD). 2️⃣ A person with metabolic syndrome + 10 drinks/day has ALD, not MetALD. @AASLDtweets @EASLedu @AEEHLiver
It's been a while since I last posted on X, but I think this is a great opportunity: the @EASLedu and @AASLDtweets Masterclass is a chance to learn about the latest developments in the field of #LiverX disease. Only a few days left to register! @EASLnews
You asked for more time to complete your application for the EASL–AASLD Masterclass 2025 — and we’re giving it to you. 🗓️ The new deadline is 13 July 2025! Take this extra time to perfect your application and get ready for an unforgettable learning experience! 🔗…
Just had the pleasure of being interviewed by @Nature on the rise of AI in digital pathology. With growing workloads and global shortages of pathologists, the field is turning to AI not as a luxury—but as a necessity. Full article: nature.com/articles/d4158… In the article, I…
Ready to take your next career step in liver disease research? Prof. @JonelTrebicka introduces #ClinicalResearch in #Hepatology, a specialization in our new Master program. Want to learn more? Fill out the form forms.office.com/e/M2p4YGNjFv and we’ll provide you with more details.
A simple blood test for bile duct cancer could be life-changing for people with PSC. We’re funding research to develop one. Hear directly from the experts behind it @JesusMBanales @PMRodrigues19 🗓️ 10 July | ⏰10am | 📍Zoom ➡️ buff.ly/saU4lSd #LetsBeatPSC @biodonostia
Please check it out !! : Original article in Hepatology International Read the full article: link.springer.com/article/10.100…
Drs. @LorenzBALCAR of @MedUni_Wien & @martatonon935 identify a #cirrhosis population with #ascites at particular risk for short-term #PortalHypertension complications @JHEP_Reports t.ly/iCvXY Ascites #Grade3 + 🚨MELD ≥12 or 🚨Na ≤135 ➡️ good candidates for #TIPS
Come work at the Leeds Liver Unit - advertising currently a Clinical fellow job where you’ll get opportunities to gain experience in liver transplant and the breadth of hepatology as well as research, education and audit! @BASLedu @BSGTrainees jobs.nhs.uk/candidate/joba…
🧠New EASL Policy Dialogue! Mind & Liver: Bridging the Gap Between Mental and Liver Health Mental and liver health are deeply connected, yet they are often treated separately. In this newly released episode, Dr. Victoria Kronsten, Kings College tells us about the hidden mental…
📊 New #ReadOfTheWeek: SPISE and METS-IR are powerful, non-invasive predictors of pediatric #MASLD 👉 Validated in NHANES (n=1,150) & real-world clinical cohort (n=260) 👉 Outperformed TG/HDL and TyG in MASLD prediction (AUCs >0.90) across sexes 👉 Optimal cut-offs: SPISE <7.004…
In today’s #readoftheweek📚, learn how METS-IR and SPISE are effective, non-invasive markers for predicting pediatric #MASLD, which offer valuable tools for early detection and improved clinical management. Read here this @JHEP_Reports article: jhep-reports.eu/article/S2589-… @yonsei_u…
Global Trend of MASH-associated Liver Cancer: A Systematic Analysis From the Global Burden of Disease 2021 @AGA_CGH doi.org/10.1016/j.cgh.… 👉42,290 cases, 40,920 deaths 🧐Growing problem, devastating numbers @myESMO @EASLedu @ILCAnews
😶Liver disease is often suffered in silence. Stigma and shame block care. 💡It’s a chronic illness, not a consequence of a bad choice. 🩺Everyone deserves support. At #LIVERAIM, we’re breaking the silence. #EndTheStigma #LiverHealthMatters #HealthEquity @IHIEurope @EASLedu
It was an honour to host the @EASLedu Basic Science School at the TGLU Oxford @TGU_Oxford @NDMOxford with a brilliant keynote from @druppygill and lots of hands on learning in the lab. Great to connect with delegates from across the world @DavidTrampert @DraMartaAlonsoP
Such a privilege to learn from all the @TGU_Oxford team! Thank you so much for your effort and kindness @TamCarg
It was an honour to host the @EASLedu Basic Science School at the TGLU Oxford @TGU_Oxford @NDMOxford with a brilliant keynote from @druppygill and lots of hands on learning in the lab. Great to connect with delegates from across the world @DavidTrampert @DraMartaAlonsoP
🚨 New #ReadOfTheWeek on the prognostic value of residual ascites post-TIPS 👉Cohort: 292 patients with cirrhosis, stratified by #ascites grade at 3 months (36% none; 28% minimal; 36% mod/sev) 👉 Minimal ascites independently predicted: 🔎further decompensation (aSHR 1.76;…
The authors in today’s #readoftheweek📚 evaluated the prognostic relevance of residual ascites grades in patients with advanced chronic liver disease after #TIPS placement. Read here this @JHEP_Reports article: jhep-reports.eu/article/S2589-… 🙏 @hartl_md, @mathiasjachs, @tiede_anja,…